Addiction and arousal: The hypocretin connection

Physiology and Behavior

Volumn 93, Issue 4-5, 2008, Pages 947-951

  Boutrel, Benjamin ^a   de Lecea, Luis ^b  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; Lateral hypothalamus; Orexin; Self administration

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; COCAINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; OREXIN A; OREXIN B;

ADDICTION; AROUSAL; ARTICLE; BEHAVIORAL SCIENCE; BRAIN FUNCTION; BRAIN REGION; DRUG MECHANISM; HUMAN; NARCOLEPSY; NERVE CELL; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; REM SLEEP; SELF STIMULATION;

EID: 40749113912     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2007.11.022     Document Type: Article

References (68)

1. de Lecea L., Kilduff T.S., Peyron C., Gao X., Foye P.E., Danielson P.E., et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 95 (1998) 322-327
2. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
3. Marcus J.N., Aschkenasi C.J., Lee C.E., Chemelli R.M., Saper C.B., Yanagisawa M., et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435 (2001) 6-25
4. Peyron C., Tighe D.K., van den Pol A.N., de Lecea L., Heller H.C., Sutcliffe J.G., et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 18 (1998) 9996-10015
5. Yoshida K., McCormack S., Espana R.A., Crocker A., and Scammell T.E. Afferents to the orexin neurons of the rat brain. J Comp Neurol 494 (2006) 845-861
6. Mignot E., Taheri S., and Nishino S. Sleeping with the hypothalamus: emerging therapeutic targets for sleep disorders. Nat Neurosci 5 (2002) 1071-1075 Suppl
7. Willie J.T., Chemelli R.M., Sinton C.M., and Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci 24 (2001) 429-458
8. Sutcliffe J.G., and de Lecea L. The hypocretins: setting the arousal threshold. Nat Rev Neurosci 3 (2002) 339-349
9. Scammell T.E. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 53 (2003) 154-166
10. Lin L., Faraco J., Li R., Kadotani H., Rogers W., Lin X., et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 98 (1999) 365-376
11. Chemelli R.M., Willie J.T., Sinton C.M., Elmquist J.K., Scammell T., Lee C., et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 98 (1999) 437-451
12. Willie J.T., Chemelli R.M., Sinton C.M., Tokita S., Williams S.C., Kisanuki Y.Y., et al. Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes. Neuron 38 (2003) 715-730
13. Hara J., Beuckmann C.T., Nambu T., Willie J.T., Chemelli R.M., Sinton C.M., et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron 30 (2001) 345-354
14. Beuckmann C.T., Sinton C.M., Williams S.C., Richardson J.A., Hammer R.E., Sakurai T., et al. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 24 (2004) 4469-4477
15. Mieda M., Willie J.T., Hara J., Sinton C.M., Sakurai T., and Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci U S A 101 (2004) 4649-4654
16. Peyron C., Faraco J., Rogers W., Ripley B., Overeem S., Charnay Y., et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 6 (2000) 991-997
17. Thannickal T.C., Moore R.Y., Nienhuis R., Ramanathan L., Gulyani S., Aldrich M., et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 27 (2000) 469-474
18. Yamanaka A., Beuckmann C.T., Willie J.T., Hara J., Tsujino N., Mieda M., et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron 38 (2003) 701-713
19. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-473
20. Lubkin M., and Stricker-Krongrad A. Independent feeding and metabolic actions of orexins in mice. Biochem Biophys Res Commun 253 (1998) 241-245
21. Dube M.G., Kalra S.P., and Kalra P.S. Food intake elicited by central administration of orexins/hypocretins: identification of hypothalamic sites of action. Brain Res 842 (1999) 473-477
22. Haynes A.C., Jackson B., Overend P., Buckingham R.E., Wilson S., Tadayyon M., et al. Effects of single and chronic intracerebroventricular administration of the orexins on feeding in the rat [in process citation]. Peptides 20 (1999) 1099-1105
23. Sweet D.C., Levine A.S., Billington C.J., and Kotz C.M. Feeding response to central orexins. Brain Res 821 (1999) 535-538
24. Espana R.A., Plahn S., and Berridge C.W. Circadian-dependent and circadian-independent behavioral actions of hypocretin/orexin. Brain Res 943 (2002) 224-236
25. Estabrooke I.V., McCarthy M.T., Ko E., Chou T.C., Chemelli R.M., Yanagisawa M., et al. Fos expression in orexin neurons varies with behavioral state. J Neurosci 21 (2001) 1656-1662
26. Zeitzer J.M., Buckmaster C.L., Lyons D.M., and Mignot E. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. J Physiol 557 (2004) 1045-1053
27. Balasko M., Szelenyi Z., and Szekely M. Central thermoregulatory effects of neuropeptide Y and orexin A in rats. Acta Physiol Hung 86 (1999) 219-222
28. Yoshimichi G., Yoshimatsu H., Masaki T., and Sakata T. Orexin-A regulates body temperature in coordination with arousal status. Exp Biol Med (Maywood) 226 (2001) 468-476
29. Dun N.J., Le Dun S., Chen C.T., Hwang L.L., Kwok E.H., and Chang J.K. Orexins: a role in medullary sympathetic outflow. Regul Pept 96 (2000) 65-70
30. Shirasaka T., Nakazato M., Matsukura S., Takasaki M., and Kannan H. Sympathetic and cardiovascular actions of orexins in conscious rats. Am J Physiol 277 (1999) R1780-R1785
31. Kayaba Y., Nakamura A., Kasuya Y., Ohuchi T., Yanagisawa M., Komuro I., et al. Attenuated defense response and low basal blood pressure in orexin knockout mice. Am J Physiol Regul Integr Comp Physiol 285 (2003) R581-R593
32. Winsky-Sommerer R., Yamanaka A., Diano S., Borok E., Roberts A.J., Sakurai T., et al. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): a novel circuit mediating stress response. J Neurosci 24 (2004) 11439-11448
33. Reyes T.M., Walker J.R., DeCino C., Hogenesch J.B., and Sawchenko P.E. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 23 (2003) 5607-5616
34. Horvath T.L., Diano S., and van den Pol A.N. Synaptic interaction between hypocretin (orexin) and neuropeptide Y cells in the rodent and primate hypothalamus: a novel circuit implicated in metabolic and endocrine regulations. J Neurosci 19 (1999) 1072-1087
35. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
36. Naveilhan P., Canals J.M., Valjakka A., Vartiainen J., Arenas E., and Ernfors P. Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. Eur J Neurosci 13 (2001) 2241-2246
37. Bannon A.W., Seda J., Carmouche M., Francis J.M., Norman M.H., Karbon B., et al. Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868 (2000) 79-87
38. Palmiter R.D., Erickson J.C., Hollopeter G., Baraban S.C., and Schwartz M.W. Life without neuropeptide Y. Recent Prog Horm Res 53 (1998) 163-199
39. Karlsson R.M., Holmes A., Heilig M., and Crawley J.N. Anxiolytic-like actions of centrally-administered neuropeptide Y, but not galanin, in C57BL/6J mice. Pharmacol Biochem Behav 80 (2005) 427-436
40. Fu L.Y., Acuña-Goycolea C., and van den Pol A.N. Neuropeptide Y inhibits hypocretin/orexin neurons by multiple presynaptic and postsynaptic mechanisms: tonic depression of the hypothalamic arousal system. J Neurosci 24 (2004) 8741-8751
41. Kalivas P.W., and McFarland K. Brain circuitry and the reinstatement of cocaine-seeking behavior. Psychopharmacology (Berl) 168 (2003) 44-56
42. Koob G.F. Stress, corticotropin-releasing factor, and drug addiction. Ann N Y Acad Sci 897 (1999) 27-45
43. Koob G.F., Sanna P.P., and Bloom F.E. Neuroscience of addiction. Neuron 21 (1998) 467-476
44. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann N Y Acad Sci 909 (2000) 170-185
45. Koob G.F. The role of the striatopallidal and extended amygdala systems in drug addiction. Ann N Y Acad Sci 877 (1999) 445-460
46. Baldo B.A., Daniel R.A., Berridge C.W., and Kelley A.E. Overlapping distributions of orexin/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress. J Comp Neurol 464 (2003) 220-237
47. Korotkova T.M., Eriksson K.S., Haas H.L., and Brown R.E. Selective excitation of GABAergic neurons in the substantia nigra of the rat by orexin/hypocretin in vitro. Regul Pept 104 (2002) 83-89
48. Martin G., Fabre V., Siggins G.R., and de Lecea L. Interaction of the hypocretins with neurotransmitters in the nucleus accumbens. Regul Pept 104 (2002) 111-117
49. Fadel J., and Deutch A.Y. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience 111 (2002) 379-387
50. Olds J., and Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol 47 (1954) 419-427
51. Anand B.K., and Brobeck J.R. Localization of a feeding center in the hypothalamus of the rat. Proc Soc Exp Biol Med 77 (1951) 323-324
52. Gallistel C.R., Shizgal P., and Yeomans J.S. A portrait of the substrate for self-stimulation. Psychol Rev 88 (1981) 228-273
53. Stricker-Krongrad A., and Beck B. Modulation of hypothalamic hypocretin/orexin mRNA expression by glucocorticoids. Biochem Biophys Res Commun 296 (2002) 129-133
54. Ida T., Nakahara K., Kuroiwa T., Fukui K., Nakazato M., Murakami T., et al. Both corticotropin releasing factor and neuropeptide Y are involved in the effect of orexin (hypocretin) on the food intake in rats. Neurosci Lett 293 (2000) 119-122
55. Ida T., Nakahara K., Murakami T., Hanada R., Nakazato M., and Murakami N. Possible involvement of orexin in the stress reaction in rats. Biochem Biophys Res Commun 270 (2000) 318-323
56. Boutrel B., Kenny P.J., Specio S.E., Martin-Fardon R., Markou A., Koob G.F., et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci U S A 102 (2005) 19168-19173
57. Macey D.J., Koob G.F., and Markou A. CRF and urocortin decreased brain stimulation reward in the rat: reversal by a CRF receptor antagonist. Brain Res 866 (2000) 82-91
58. Markou A., and Koob G.F. Postcocaine anhedonia. An animal model of cocaine withdrawal. Neuropsychopharmacology 4 (1991) 17-26
59. Epping-Jordan M.P., Watkins S.S., Koob G.F., and Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature 393 (1998) 76-79
60. Harris G.C., Wimmer M., and Jones G.A. A role for lateral hypothalamic orexin neurons in reward seeking. Nature 437 (2005) 556-559
61. Wang B., Shaham Y., Zitzman D., Azari S., Wise R.A., and You Z.B. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J Neurosci 25 (2005) 5389-5396
62. Burlet S., Tyler C.J., and Leonard C.S. Direct and indirect excitation of laterodorsal tegmental neurons by hypocretin/orexin peptides: implications for wakefulness and narcolepsy. J Neurosci 22 (2002) 2862-2872
63. Korotkova T.M., Sergeeva O.A., Eriksson K.S., Haas H.L., and Brown R.E. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci 23 (2003) 7-11
64. Borgland S.L., Taha S.A., Sarti F., Fields H.L., and Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron 49 (2006) 589-601
65. Koob G.F., and Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278 (1997) 52-58
66. Shalev U., Morales M., Hope B., Yap J., and Shaham Y. Time-dependent changes in extinction behavior and stress-induced reinstatement of drug seeking following withdrawal from heroin in rats. Psychopharmacology (Berl) 156 (2001) 98-107
67. Georgescu D., Zachariou V., Barrot M., Mieda M., Willie J.T., Eisch A.J., et al. Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23 (2003) 3106-3111
68. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neurosci Biobehav Rev 27 (2004) 739-749